Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Good
|
Filing tables
Filing exhibits
- 10-K Annual report
- 10.27 Lease Contract
- 21.1 Subsidiaries of the Registrant
- 31.1 Certification by the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-oxley Act of 2002 and Rules 13A-14 and 15D-14 Under the Securities Exchange Act of 1934
- 31.2 Certification by the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-oxley Act of 2002 and Rules 13A-14 and 15D-14 Under the Securities Exchange Act of 1934
- 32 Certification of Periodic Financial Report by the Chief Executive Officer and Chief Financial Officer Pursuant to Section 906 of the Sarbanes-oxley Act of 2002
YEWB similar filings
Filing view
External links
EXHIBIT 21.1
Subsidiaries of Yew Bio-Pharm Group, Inc.
Entity | Jurisdiction of Organization | Percentage Owned | ||
Yew Bio-Pharm Holdings Limited | Hong Kong | 100% | ||
Heilongjiang Jinshangjing Bio-Technology Development Co., Limited | People’s Republic of China | 100% | ||
Harbin Yew Science and Technology Development Co., Ltd. | People’s Republic of China | Variable interest entity |